Revumenib Citrate
Revumenib (SNDX-5613) is a potent and selective small molecule inhibitor of the Menin-MLL interaction, used for researching MLL-rearranged leukemias such as ALL and AML. It has demonstrated activity in both in vitro cellular assays and in vivo xenograft models, supporting its investigation as a targeted therapeutic agent.
Product Specifications
CAS Number
2761046-45-9
Smiles
C (CC (O) =O) (CC (O) =O) (C (O) =O) O.C (N1CCC2 (CN (C2) C=3C (OC4=C (C (N (C (C) C) CC) =O) C=C (F) C=C4) =CN=CN3) CC1) [C@@H]5CC[C@@H] (NS (CC) (=O) =O) CC5.O
Molecular Formula
C38H57FN6O12S
Molecular Weight
840.96
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
